Skip to main content

Advertisement

SpringerLink
Log in

Sinomenine reduces invasion and migration ability in fibroblast-like synoviocytes cells co-cultured with activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, CD147

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

CD147 expressed by monocytes, macrophages, and synoviocytes cells can stimulate the production of matrix metalloproteinases (MMPs) associated with the development of rheumatoid arthritis (RA). We investigated the effects of Sinomenine (SIN) on invasion and migration ability and gene expression of CD147, MMP-2, MMP-9 of fibroblast-like synoviocytes cells (FLS) co-cultured with activated human monocytic THP-1 cells (A-THP-1) in vitro. SIN is a pure alkaloid extracted from the Chinese medical plant Sinomenium acutum. FLS cells were co-cultured with THP-1 cells which were induced to differentiate into macrophages with phorbol 12-myristate 13-acetate (PMA). Cells were treated with different concentrations of SIN. Invasion and migration ability of cells was tested by transwell assays. Western blot analysis and zymographic analysis were adopted to detect the expression of CD147 and MMPs, respectively. RT–PCR was used to determine the expression of mRNA of CD147, MMP-2, and MMP-9. The invasion and migration ability of the co-cultured cells was significantly inhibited by SIN in a concentration-dependent fashion, and at the same time, the levels of CD147, MMP-2, MMP-9 were markedly down-regulated. This inhibitory effect was most notable at concentrations of 0.25 and 1.00 mM (P < 0.01). Our results point to a possible mechanism of SIN on treatment of RA is the inhibitory effect of SIN on cell invasion and migration ability, which strongly correlates with repressing the expression of CD147, MMP-2, and MMP-9.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ke XY, Xiu MX (1986) Treatment of rheumatoid arthritis by sinomenine. Beijing Yixue 3:186–187

    Google Scholar 

  2. Shi PM, Ma ZX, Zhang WZ (1985) History of Chinese medicine. Xien Yi Xue 3:292–293

    Google Scholar 

  3. Liu ZQ, Kelvin C, Zhou H, Jiang ZH, Wong WF (2005) The pharmacokinetics and tissue distribution of sinomenine in rats and its protein binding ability in vitro. Life Sci 77:3197–3209

    Article  PubMed  CAS  Google Scholar 

  4. Noriaki N, Takashi F, Yoshimasa I, Shigeyuki U, Kazuyuki H (2009) Preventive effect of co-administration of water containing magnesium ion on indomethacin induced lesions of gastric mucosa in adjuvant-induced arthritis rat. Biol Pharm Bull 32:116–120

    Article  Google Scholar 

  5. Li XJ, Patrick YK, Ha WY, Daisy YL, Mandy MY, Wang PX (2006) Effect of sinomenine on gene expression of the IL-1β-activated human synovial sarcoma. Life Sci 79:665–673

    Article  PubMed  CAS  Google Scholar 

  6. Yamasaki H (1976) Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum. Acta Med Okayama 30:1–20

    PubMed  CAS  Google Scholar 

  7. Li F, Li XF, Hu XF (2005) The serum matrix metalloproteinase- 9 level and it′s significance in rheumatoid arthritis. Chin J Rheumatol 9:9–11

    Google Scholar 

  8. Eric EG, Thanh HX, Alain M, Suzanne M (2005) EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 87:361–368

    Article  Google Scholar 

  9. Liu JH, Li WD, Teng HL, Lin ZB (2005) Immunopharmacological action of sinomenine, an alkaloid isolated from Sinomenium acutum, and its mechanism of action in treating rheumatoid arthritis. Acta Pharmaceu Sin 40:127–131

    CAS  Google Scholar 

  10. Liu L, Buchner E, Beitze D, Schmidt CB, Kaever V, Emmrich F (1996) Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int Immunopharmacol 18:529–543

    Article  CAS  Google Scholar 

  11. Kok TW, Yue PY, Mak NK, Fan TP, Liu L, Wong RN (2005) The anti-angiogenic effect of sinomenine. Angiogenesis 8:3–12

    Article  PubMed  CAS  Google Scholar 

  12. Wu ZB, Zhu P, Lu N, Shi ZG, Fan CM, Wang YH (2005) Enhanced production of MMP-2, MMP-9 by fibroblast cells from rheumatoid arthritis patients when co-cultured with monocytes of high CD147 expression. Chin J Rheumatol 5:26–27

    Google Scholar 

  13. Ou YQ, Chen LH, Li XJ, Lin ZB (2009) Sinomenine influences invasion and migration ability by inhibiting the expression of MMP-2, MMP-9, CD147 in activated human monocytic THP-1 cells. Acta Pharmacol Sin 30:435–441

    Article  PubMed  CAS  Google Scholar 

  14. Tae H, Kim KW, Suh SJ, Kwak CG, Kima JK, Kimb CH (2007) Inhibitory effect of Uncaria sinensis on human aortic smooth muscle cell migration is based on matrix metalloproteinase-9 inhibitory. Environ Toxicol Phar 24:218–222

    Article  Google Scholar 

  15. Jin MH, Yang JH, Lee E, Lu Y, Kwon S, Son KH, Son JK, Chang HW (2009) Antiasthmatic activity of luteolin-7-O-glucoside from Ailanthus altissima through the downregulation of T helper 2 cytokine expression and inhibition of prostaglandin E2 production in an ovalbumin-induced asthma model. Biol Pharm Bull 32:1500–1503

    Article  PubMed  CAS  Google Scholar 

  16. Kuang YH, Chen X, Su J, Wu LS, Liao LQ, Li D, Chen ZS, Takuro K (2008) RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletion. Cancer letter 10:10–16

    Google Scholar 

  17. Sun X, Zhang XD, Hu H, Lu Y, Chen J, Yasuda K, Wang H (2009) Berberine inhibits hepatic stellate cell proliferation and prevents experimental liver fibrosis. Biol Pharm Bull 32:1533–1537

    Article  PubMed  CAS  Google Scholar 

  18. Kataoka H, DeCastro R, Zucker S, Biswas C (1993) Tumor cell-derived collagenase -stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 53:3154–3158

    PubMed  CAS  Google Scholar 

  19. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T (2006) Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology 45:669–675

    Article  PubMed  CAS  Google Scholar 

  20. Pap T, Gay S, Schett G (2002) Matrix metalloproteinases. In: Smolen J, Lipsky J, Dunitz M (eds)Targeted therapies in rheumatology, pp 483–497

  21. Amorino GP, Hoover RL (1998) Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. Am J Pathol 152:199–207

    PubMed  CAS  Google Scholar 

  22. Guo H, Zucker S, Gordon MK, Toole BP, Biswas C (1997) Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 272:24–27

    Article  PubMed  CAS  Google Scholar 

  23. Sun J, Hemler ME (2001) Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 61:2276–2281

    PubMed  CAS  Google Scholar 

  24. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K (1995) The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55:434–439

    PubMed  CAS  Google Scholar 

  25. Guo H, Majmudar G, Jensen TC, Biswas C, Toole BP, Gordon MK (1998) Characterization of the gene for human EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases. Gene 220:99–108

    Article  PubMed  CAS  Google Scholar 

  26. Liang L, Terry M, Thomas B (2002) Characterization of the promoter of human extracellular matrix metalloproteinase inducer (EMMPRIN). Gene 282:75–86

    Article  PubMed  CAS  Google Scholar 

  27. Dong WJ, Zhu P, Fan CM, Wang YH, Xiao LB (2004) Expression of CD147 and matrix metalloproteinases in rheumatoid synovium. Chin J Rheumatol 8:135–138

    Google Scholar 

Download references

Acknowledgments

The authors are very grateful to Dr. Michael A. McNutt and Dr. xiaoling-ZHU for revising this paper.

Author information

Authors and Affiliations

  1. Laboratory of Immunopharmacology, Department of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, 100191, Beijing, People’s Republic of China

    Yangqiong Ou, Weidong Li, Xuejun Li, Zhibin Lin & Min Li

Authors
  1. Yangqiong Ou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Weidong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xuejun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhibin Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Min Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yangqiong Ou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ou, Y., Li, W., Li, X. et al. Sinomenine reduces invasion and migration ability in fibroblast-like synoviocytes cells co-cultured with activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, CD147. Rheumatol Int 31, 1479–1485 (2011). https://doi.org/10.1007/s00296-010-1506-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1506-2

Keywords

Search

Navigation